Acthib Kit
Product Images NDC 49281-545

7 FDA label images from Sanofi Vaccines Us Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acthib (NDC 49281-545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (8143d01c 4911 40db 95b2 47f3ebea2a7d 01)

Figure 1 (8143d01c 4911 40db 95b2 47f3ebea2a7d 01)
Illustration showing a vaccine vial labeled with a partially visible 'IDEN' and a syringe attached below it, indicating a volume of 0.6 mL to be drawn from the vial. The image steps through the preparation process of the injection, with an arrow pointing downward from the vial to the syringe.*
FDA Label Image

Figure 2 (8143d01c 4911 40db 95b2 47f3ebea2a7d 02)

Figure 2 (8143d01c 4911 40db 95b2 47f3ebea2a7d 02)
An instructional diagram showing a syringe inserted into a vial labeled ActHIB, with a downward arrow indicating the action of drawing the vaccine from the vial.*
FDA Label Image

Figure 3 (8143d01c 4911 40db 95b2 47f3ebea2a7d 03)

Figure 3 (8143d01c 4911 40db 95b2 47f3ebea2a7d 03)
An instructional illustration showing hands assembling components of a vaccine kit, likely depicting the preparation steps for ActHIB vaccine. The image features three vials or containers being handled for the mixing or preparation process.*
FDA Label Image

Figure 4 (8143d01c 4911 40db 95b2 47f3ebea2a7d 04)

Figure 4 (8143d01c 4911 40db 95b2 47f3ebea2a7d 04)
An instructional illustration showing a syringe drawing 0.5 mL of liquid from a vial labeled with a code. An arrow points downward, indicating the direction to pull or withdraw fluid.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for ActHIB Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) kit by Sanofi Pasteur. The label indicates 5 single-dose vials for children 2 months through 5 years of age. Includes reconstitution instructions using 0.6 mL diluent and storage conditions at 2°C to 8°C, with warning not to freeze. Contains product and manufacturer information, a barcode, and usage cautions.*
FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
Label for ActHIB single-dose (0.5 mL) Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) kit component. Warning states not to use alone; requires reconstitution with Saline Diluent Component. Manufactured by Sanofi Pasteur SA. Includes NDC 49281-547-58 and space for lot and expiration dates.*
FDA Label Image

Principal Display Panel (0.6 mL Vial Label)

Principal Display Panel (0.6 mL Vial Label)
Label for ActHIB saline diluent component, part of a kit for reconstitution of Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate). It indicates a single-dose of 0.6 mL with 0.4% sodium chloride, marked as not to be used alone and is labeled by Sanofi Pasteur Inc. in Swiftwater, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.